SCHEMBL13637264

SCHEMBL13637264

Cc1cccn2cc(-c3ccc(C[C@@H](CN4CCCC4O)NC(=O)c4ccc(OC(C)C)c(Cl)c4)cc3)nc12

nearest known ligand 0.60

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CENPE Q02224 3/20 0.60
KDM4E B2RXH2 5/20 0.42
ALDH1A1 P00352 4/20 0.42
KMT2A Q03164 2/20 0.42
MAPT P10636 2/20 0.42
HPGD P15428 1/20 0.42
HRH3 Q9Y5N1 3/20 0.41
MEN1 O00255 1/20 0.38
POLB P06746 2/20 0.37
SMN1; SMN2 Q16637 4/20 0.37
NPC1 O15118 3/20 0.37
RAB9A P51151 3/20 0.37
TSHR P16473 1/20 0.37
MAPK1 P28482 1/20 0.37
HSD17B10 Q99714 1/20 0.37
PKM P14618 1/20 0.37
KIFC1 Q9BW19 1/20 0.36
WDR5 P61964 1/20 0.36
TP53 P04637 1/20 0.36
MAP4K4 O95819 1/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL2105793 0.93 CENPE (0.60) CENPEKDM4EALDH1A1KMT2AMAPT
SCHEMBL2105756 0.93 CENPE (0.60) CENPEKDM4EALDH1A1KMT2AMAPT
SCHEMBL2105182 0.90 CENPE (0.61) CENPEKDM4EALDH1A1KMT2AMAPT
SCHEMBL2104605 0.89 CENPE (0.61) CENPEKDM4EALDH1A1KMT2AMAPT
SCHEMBL2104936 0.87 CENPE (0.71) CENPEKDM4EALDH1A1KMT2AMAPT
SCHEMBL2104554 0.87 CENPE (0.62) CENPEKDM4EALDH1A1KMT2AMAPT
SCHEMBL2102560 0.86 CENPE (0.68) CENPEKDM4EALDH1A1KMT2AMAPT
SCHEMBL4554543 0.86 CENPE (0.68) CENPEKDM4EALDH1A1KMT2AMAPT
SCHEMBL2104176 0.85 CENPE (0.80) CENPEKDM4EALDH1A1KMT2AMAPT
SCHEMBL3462266 0.85 CENPE (0.80) CENPEKDM4EALDH1A1KMT2AMAPT

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20090286841-A1 CERTAIN CHEMICAL ENTITIES, COMPOSITIONS, AND METHODS CYTOKINETICS, INC. 2009-11-19 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20090286841-A1 CERTAIN CHEMICAL ENTITIES, COMPOSITIONS, AND METHODS KIF5B, KIF2C, PLK1 CENPE 54/4885KDM4E 3267/4885ALDH1A1 2159/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.